Nurix Therapeutics
NRIX
NRIX
101 hedge funds and large institutions have $1.28B invested in Nurix Therapeutics in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 39 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
18% more capital invested
Capital invested by funds: $1.09B → $1.28B (+$196M)
8.01% more ownership
Funds ownership: 85.28% → 93.29% (+8%)
67% less call options, than puts
Call options by funds: $6K | Put options by funds: $18K
Holders
101
Holding in Top 10
8
Calls
$6K
Puts
$18K
Top Buyers
| 1 | +$77.8M | |
| 2 | +$32.2M | |
| 3 | +$28.8M | |
| 4 |
Jennison Associates
New York
|
+$22.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$20.7M |
Top Sellers
| 1 | -$34.5M | |
| 2 | -$33.8M | |
| 3 | -$28.4M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$7.57M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$5.3M |